Medical News

RSS

TONES procedure is safe and effective for treating brain diseases, traumatic injuries

Surgeons at the University of California, San Diego, School of Medicine and University of Washington Medical Center have determined that transorbital neuroendoscopic surgery is a safe and effective option for treating a variety of advanced brain diseases and traumatic injuries. This groundbreaking minimally invasive surgery is performed through the eye socket, thus eliminating the removal of the top of the skull to access the brain.

27 Sep 2010

MediciNova receives FDA approval to proceed with initial trial of ibudilast

MediciNova Inc, a biopharmaceutical company publicly traded on the NASDAQ Global Market and the Hercules Market of the Osaka Securities Exchange (Code Number:4875), today reported FDA's approval to proceed with an initial trial of the company's neurological drug candidate, ibudilast (MN-166/AV411), as a potential new pharmacotherapy for methamphetamine addiction.

27 Sep 2010

Rotech Healthcare offers $225 million in Senior Secured Notes due 2015

Rotech Healthcare Inc. announced today that the company intends to offer, subject to market and other conditions, $225 million in aggregate principal amount of Senior Secured Notes due 2015.

27 Sep 2010

The Children's Hospital, Denver Health sign Affiliation Agreement to care for children of all ages

The Children's Hospital and Denver Health have signed an official Affiliation Agreement to leverage the substantial strengths of both institutions to provide outstanding programs in pediatric patient care, education, research and advocacy. Under the agreement, two of the largest pediatric health care providers in the region are able to provide improved access for patients, share best practices and more efficiently use resources.

27 Sep 2010

Condoms can prevent transmission of herpes simplex virus 2: Study

Condom use is associated with a reduced risk of contracting herpes simplex virus 2, according to a report based on pooled analysis of data from previous studies in the July 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

27 Sep 2010

Study shows regadenoson is safe and effective for chronic lung disease

Patients at risk of coronary disease who have reactive airways may breathe easier thanks to new data released today at the 15th Annual Scientific Session of the American Society of Nuclear Cardiology. A new study shows that regadenoson may be safely tolerated by patients with chronic lung disease, providing an alternative to adenosine, which is known to induce brochoconstriction in some patients.

27 Sep 2010

Researchers identify cellular/molecular defect in T cell regulatory pathway

Researchers at Columbia University Medical Center have identified a defect in the T cell regulatory pathway which normally controls autoreactive T cells that attack the body's own tissues and organs. A majority of people with Type 1 diabetes who were tested in the study were found to have the newly-identified cellular/molecular defect, and the researchers were able to successfully correct the defect in-vitro.

27 Sep 2010

GBS pathogen suppresses immune cell function in newborn infants: Research

Group B Streptococcus (GBS), a bacterial pathogen that causes sepsis and meningitis in newborn infants, is able to shut down immune cell function in order to promote its own survival, according to researchers at the University of California, San Diego School of Medicine and the Skaggs School of Pharmacy and Pharmaceutical Sciences.

27 Sep 2010

JAMA issue unveils genetic signature of brain cancer

A pair of studies in the July 15 issue of the Journal of the American Medical Association (JAMA) spell out how much closer science has come to unraveling the genetic signature of brain cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

27 Sep 2010

Breast cancer survivors with functional limitations more likely to die of poorer health: Study

Basic physical limitations following breast cancer treatment can have far-reaching consequences that substantially affect how long a patient lives.

27 Sep 2010

Takeda announces SGN-35 ADC trial results in Hodgkin lymphoma patients

Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, today announced positive top line results from the pivotal trial of single agent brentuximab vedotin (SGN-35), an antibody drug conjugate (ADC) targeted to CD30. The trial was conducted in 102 relapsed or refractory Hodgkin lymphoma (HL) patients.

27 Sep 2010

NAPHS 2011 Membership Directory provides information on nation's behavioral healthcare systems

The National Association of Psychiatric Health Systems has published a 2011 Membership Directory. The directory is a comprehensive referral resource providing information on the nation's behavioral healthcare systems.

27 Sep 2010

Adolescent girls who have abortions no more likely to become depressed: Study

A new study has determined that teenagers who have abortions are no more likely to become depressed or have low self-esteem than their peers whose pregnancies do not end in abortion.

27 Sep 2010

Participants at ICRE 2010 program urge medical community to adopt new resident training methods

Presenters at an international medical conference in Ottawa today urged their colleagues from around the world to adopt fundamental changes to postgraduate medical education for residents that would ultimately improve outcomes for patients.

27 Sep 2010

Parascript receives CE Mark for AccuDetect software

Parascript, LLC, the image analysis and pattern recognition technology provider, today announced that it received CE (Conformite Europeenne) Mark for AccuDetect Galileo Computer Aided Detection (CAD) software.

27 Sep 2010

OncoGenex initiates OGX-427 Phase 2 trial for metastatic prostate cancer

OncoGenex Pharmaceuticals, Inc. announced today the initiation of a randomized, controlled, investigator sponsored Phase 2 trial of OGX-427 in men with metastatic prostate cancer.

27 Sep 2010

Hospira's Nivestim receives Australian TGA approval

Hospira, Inc., the world leader in generic injectable pharmaceuticals, today announced that it has received Australian Therapeutic Goods Administration approval for its biosimilar filgrastim product, Nivestim.

27 Sep 2010

People with Parkinson's disease have high levels of beta-HCH pesticide

People with Parkinson's disease have significantly higher blood levels of a particular pesticide than healthy people or those with Alzheimer's disease, researchers at UT Southwestern Medical Center have found.

27 Sep 2010

HHS Secretary announces $30M to expand HIV prevention efforts under President's NHAS

U.S. Department of Health and Human Services Secretary Kathleen Sebelius today announced that CDC has allocated $30 million of the Affordable Care Act's Prevention and Public Health Fund to expand HIV prevention efforts under the President's National HIV/AIDS Strategy. This includes $21.6 million in grants to state and local health departments.

27 Sep 2010

Early recipient of transcatheter aortic valve receives Courageous Patient Award

Lillian Feldshuh, of Scarsdale, NY, an early recipient of a transcatheter aortic valve in 2006, received the Courageous Patient Award yesterday at the Transcatheter Cardiovascular Therapeutics scientific symposium in Washington, DC. The procedure was a success and Feldshuh, who will turn 100 years in just 7 months, remains in good health.

27 Sep 2010